Submitted by Anonymous (not verified) on 11 March 2025 - 15:30
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Status: Authorised